Cite Filings / FULC / 0001193125-26-353282
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
425

Prospectus/Communication re Business Combination

Fulcrum Therapeutics, Inc. · Filed 2026-08-17 · Acc 0001193125-26-353282

Documents 1

  • 425 Prospectus/Communication re Business Combination , d403747d425.htm

Around this filing

  • 2026-08-17 425 Prospectus/Communication re Business Combination
  • 2026-08-17 425 Prospectus/Communication re Business Combination
  • 2026-08-17 425 Prospectus/Communication re Business Combination
  • 2026-08-17 8-K Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d403747d425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…